The field of stem cell therapy is experiencing rapid development, attracting both substantial investment and heightened public attention. This multifaceted financial landscape is defined by a range of factors, including regulatory frameworks, research costs, and the evolving demands of the market. Deciphering this landscape is essential for both in

Glaucoma, a condition that damages the optic nerve and can lead to vision loss, often requires surgical intervention. Fortunately, minimally invasive glaucoma surgery (MIGS) offers a less disruptive alternative to traditional procedures. These techniques involve small incisions and minimal tissue manipulation, resulting in quicker recovery times, r